The DOI matches its Crossref record; 161 of the 161 references it cites were found in a registry or an index.
Plasma membrane monoamine transporters: structure, regulation and function
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lesch, K.-P., Bengel, D., Heils, A., Sabol, S. Z., Greenberg, B. D., Petri, S., Benjamin, J., Müller, C. R., Hamer, D. H., & Murphy, D. L. (1996) · Science · doi:10.1126/science.274.5292.1527 · Cited by 5,162
Psychopharmacology: The Fourth Generation of Progress
Bloom, F. E., & Kupfer, D. J. (1995) · Medical Entomology and Zoology · Cited by 2,985
Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter
Giros, B., Jaber, M., Jones, S. R., Wightman, R. M., & Caron, M. G. (1996) · Nature · doi:10.1038/379606a0 · Cited by 2,476
Self-citationCocaine Receptors on Dopamine Transporters Are Related to Self-Administration of Cocaine
Ritz, M. C., Lamb, R. J., Goldberg, S. R., & Kuhar, M. J. (1987) · Science · doi:10.1126/science.2820058 · Cited by 2,180
Psychopharmacology: The Fourth Generation of Progress
Brophy, J. J. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03530220079046 · Cited by 1,582
Association of attention-deficit disorder and the dopamine transporter gene.
Cook, E. H., Stein, M. A., Krasowski, M. D., Cox, N. J., Olkon, D. M., Kieffer, J. E., & LEVENTHAL, B. L. (1995) · PubMed · Cited by 1,168
Wise, R. A. (1996) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(96)80079-1 · Cited by 1,072
Expression cloning of a cocaine-and antidepressant-sensitive human noradrenaline transporter
Pacholczyk, T., Blakely, R. D., & Amara, S. G. (1991) · Nature · doi:10.1038/350350a0 · Cited by 933
Role of Serotonin in the Paradoxical Calming Effect of Psychostimulants on Hyperactivity
Gainetdinov, R. R., Wetsel, W. C., Jones, S. R., Levin, E. D., Jaber, M., & Caron, M. G. (1999) · Science · doi:10.1126/science.283.5400.397 · Cited by 885
Self-citationRamamoorthy, S., Bauman, A. L., Moore, K. R., Han, H., Yang-Feng, T., Chang, A. S., Ganapathy, V, & Blakely, R. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.6.2542 · Cited by 880
Cited by
Crystal structure of a bacterial homologue of Na+/Cl--dependent neurotransmitter transporters
Yamashita, A., Singh, S. K., Kawate, T., Jin, Y., & Gouaux, E. (2005) · Nature · doi:10.1038/nature03978 · Cited by 1,661
Reigstad, C. S., Salmonson, C. E., III, J. F. R., Szurszewski, J. H., Linden, D. R., Sonnenburg, J. L., Farrugia, G., & Kashyap, P. C. (2015) · The FASEB Journal · doi:10.1096/fj.14-259598 · Cited by 1,335
SLC6 Neurotransmitter Transporters: Structure, Function, and Regulation
Kristensen, A. S., Andersen, J., Jørgensen, T. N., Sørensen, L., Eriksen, J., Loland, C. J., Strømgaard, K., & Gether, U. (2011) · Pharmacological Reviews · doi:10.1124/pr.108.000869 · Cited by 864
Sheldon, A. L., & Robinson, M. B. (2007) · Neurochemistry International · doi:10.1016/j.neuint.2007.03.012 · Cited by 594
Millan, M. J. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.11.006 · Cited by 551
MOHAMMAD‐ZADEH, L. F., MOSES, L., & GWALTNEY‐BRANT, S. M. (2008) · Journal of Veterinary Pharmacology and Therapeutics · doi:10.1111/j.1365-2885.2008.00944.x · Cited by 522
MiR-16 Targets the Serotonin Transporter: A New Facet for Adaptive Responses to Antidepressants
Baudry, A., Mouillet-Richard, S., Schneider, B., Launay, J.-M., & Kellermann, O. (2010) · Science · doi:10.1126/science.1193692 · Cited by 480
An Update on the Mechanisms of the Psychostimulant Effects of Caffeine
Ferré, S. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05196.x · Cited by 440
Vesicular glutamate transport promotes dopamine storage and glutamate corelease in vivo
Hnasko, T. S., Chuhma, N., Zhang, H., Goh, G. Y., Sulzer, D., Palmiter, R. D., Rayport, S., & Edwards, R. H. (2010) · Neuron · doi:10.1016/j.neuron.2010.02.012 · Cited by 405
“Cocaine increases extracellular dopamine by inhibiting its reuptake, stimulating locomotor activity through a mechanism that depends first on exocytotic dopamine release (Torres et al., 2003; Uhl et al., 2002).”
BackgroundKim, K., Lee, S., Kegelman, T. P., Su, Z., Das, S. K., Dash, R., Dasgupta, S., Barral, P. M., Hedvat, M., Diaz, P., et al. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22609 · Cited by 395
Transporters for L‐glutamate: An update on their molecular pharmacology and pathological involvement
Beart, P. M., & O'Shea, R. D. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706949 · Cited by 377
Shi, L., Quick, M., Zhao, Y., Weinstein, H., & Javitch, J. A. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.05.008 · Cited by 375
The monoamine neurotransmitter disorders: an expanding range of neurological syndromes
Kurian, M. A., Gissen, P., Smith, M., Heales, S. J., & Clayton, P. T. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70141-7 · Cited by 351
Acharya, C., Coop, A., E. Polli, J., & D. MacKerell, A. (2011) · Current Computer Aided-Drug Design · doi:10.2174/157340911793743547 · Cited by 340
LeuT-Desipramine Structure Reveals How Antidepressants Block Neurotransmitter Reuptake
Zhou, Z., Zhen, J., Karpowich, N. K., Goetz, R. M., Law, C. J., Reith, M. E. A., & Wang, D.-N. (2007) · Science · doi:10.1126/science.1147614 · Cited by 333
Choline Transport for Phospholipid Synthesis
Michel, V., Yuan, Z., Ramsubir, S., & Bakovic, M. (2006) · Experimental Biology and Medicine · doi:10.1177/153537020623100503 · Cited by 317
Substrate-modulated gating dynamics in a Na+-coupled neurotransmitter transporter homologue
Zhao, Y., Terry, D. S., Shi, L., Quick, M., Weinstein, H., Blanchard, S. C., & Javitch, J. A. (2011) · Nature · doi:10.1038/nature09971 · Cited by 311
Neurotransmitter transporters: molecular function of important drug targets
GETHER, U., ANDERSEN, P., LARSSON, O., & SCHOUSBOE, A. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.05.003 · Cited by 309
Organic Cation Transporters in Health and Disease
Koepsell, H. (2020) · Pharmacological Reviews · doi:10.1124/pr.118.015578 · Cited by 297
Mathews, T. A., Fedele, D. E., Coppelli, F. M., Avila, A. M., Murphy, D. L., & Andrews, A. M. (2004) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2004.05.017 · Cited by 276
The solute carrier 6 family of transporters
Bröer, S., & Gether, U. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01975.x · Cited by 269
Identification and Characterization of a Novel Monoamine Transporter in the Human Brain
Engel, K., Zhou, M., & Wang, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407913200 · Cited by 267
Millan, M. J. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.07.038 · Cited by 255
Single-molecule dynamics of gating in a neurotransmitter transporter homologue
Zhao, Y., Terry, D., Shi, L., Weinstein, H., Blanchard, S. C., & Javitch, J. A. (2010) · Nature · doi:10.1038/nature09057 · Cited by 255
Amphetamine induces dopamine efflux through a dopamine transporter channel
Kahlig, K. M., Binda, F., Khoshbouei, H., Blakely, R. D., McMahon, D. G., Javitch, J. A., & Galli, A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407737102 · Cited by 239
Amphetamine and methamphetamine differentially affect dopamine transporters in vitro and in vivo.
Goodwin, J. S., Larson, G. A., Swant, J., Sen, N., Javitch, J. A., Zahniser, N. R., De Felice, L. J., & Khoshbouei, H. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m805298200 · Cited by 203
Borovac, J. A., D'Amario, D., Bozic, J., & Glavas, D. (2020) · World Journal of Cardiology · doi:10.4330/wjc.v12.i8.373 · Cited by 195
Phenotype and genotype in 101 males with X-linked creatine transporter deficiency
van de Kamp, J. M., Betsalel, O. T., Mercimek-Mahmutoglu, S., Abulhoul, L., Grünewald, S., Anselm, I., Azzouz, H., Bratkovic, D., de Brouwer, A., Hamel, B., et al. (2013) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2013-101658 · Cited by 164
Vesicular and Plasma Membrane Transporters for Neurotransmitters
Blakely, R. D., & Edwards, R. H. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a005595 · Cited by 169
Neumeister, A., Hu, X.-Z., Luckenbaugh, D. A., Schwarz, M., Nugent, A. C., Bonne, O., Herscovitch, P., Goldman, D., Drevets, W. C., & Charney, D. S. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.9.978 · Cited by 161
Provenzi, L., Giorda, R., Beri, S., & Montirosso, R. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.08.021 · Cited by 139
Chemical transmission in the sea anemone Nematostella vectensis: a genomic perspective
Anctil, M. (2009) · Comparative Biochemistry and Physiology Part D Genomics and Proteomics · doi:10.1016/j.cbd.2009.07.001 · Cited by 139
Narayanan, V., Heiming, R. S., Jansen, F., Lesting, J., Sachser, N., Pape, H.-C., & Seidenbecher, T. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022600 · Cited by 103
SPECT and PET of the dopamine transporter in attention-deficit/hyperactivity disorder
Krause, J. (2008) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.8.4.611 · Cited by 110
Kinase-dependent Regulation of Monoamine Neurotransmitter Transporters
Bermingham, D. P., & Blakely, R. D. (2016) · Pharmacological Reviews · doi:10.1124/pr.115.012260 · Cited by 97
Illicit dopamine transients: reconciling actions of abused drugs
Covey, D. P., Roitman, M. F., & Garris, P. A. (2014) · Trends in Neurosciences · doi:10.1016/j.tins.2014.02.002 · Cited by 90
Bailey, C. R., Cordell, E., Sobin, S. M., & Neumeister, A. (2013) · CNS Drugs · doi:10.1007/s40263-013-0051-4 · Cited by 89
Liu, X., Vilenski, O., Kwan, J., Apparsundaram, S., & Weikert, R. (2009) · Drug Metabolism and Disposition · doi:10.1124/dmd.109.026674 · Cited by 75
Raber, J., Arzy, S., Bertolus, J. B., Depue, B., Haas, H. E., Hofmann, S. G., Kangas, M., Kensinger, E., Lowry, C. A., Marusak, H. A., et al. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.03.015 · Cited by 62
“The serotonin transporter clears serotonin from the synapse, consequently determining the duration and extent of serotonergic synaptic neurotransmission (Blakely et al., 1994; Torres et al., 2003).”
Tian, G., Hui, M., Macchia, D., Derdeyn, P., Rogers, A., Hubbard, E., Liu, C., Vasquez, J. J., Taniguchi, L., Bartas, K., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110775 · Cited by 31
Shiotani, A., Kusunoki, H., Kimura, Y., Ishii, M., Imamura, H., Tarumi, K.-I., Manabe, N., Kamada, T., Hata, J., & Haruma, K. (2013) · Digestive Diseases and Sciences · doi:10.1007/s10620-013-2677-y · Cited by 26
Strengths and limitations of genetic models of ADHD
Gainetdinov, R. R. (2010) · ADHD Attention Deficit and Hyperactivity Disorders · doi:10.1007/s12402-010-0021-3 · Cited by 24
Self-citationEnhanced dopamine transporter function in striatum during nicotine withdrawal
Hadjiconstantinou, M., Duchemin, A., Zhang, H., & Neff, N. H. (2011) · Synapse · doi:10.1002/syn.20820 · Cited by 20
Deciphering Ibogaine’s Matrix Pharmacology: Multiple Transporter Modulation at Serotonin Synapses
Hwu, C., Havel, V., Westergaard, X., Mendieta, A. M., Serrano, I. C., Hwu, J., Walther, D., Lankri, D., Selinger, T. L., He, K., et al. (2025) · doi:10.1101/2025.03.04.641351 · Cited by 7
“37,38 41 There are also targets for monoamine releasers, such as amphetamine and MDMA, that act as MAT substrates and induce efflux of native monoamine transmitters via these transporters, often referred to as “reverse transport”.”
Metadata
- Authors
- Torres, G. E., Gainetdinov, R. R., & Caron, M. G.
- Venue
- Nature Reviews Neuroscience
- Published
- 2003-01
- Volume
- 4
- Issue
- 1
- Pages
- 13-25
- ISSN
- 1471-003X (ISSN-L)
- 1471-0048
- OpenAlex
- W2064225780
- Cited by
- 939
- References
- 161
- FWCI
- 2.82
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.